Cargando…

Isotretinoin-Induced Delusional Disorder, Somatic Subtype

Isotretinoin, an active form of vitamin A, is the drug of last resort for the treatment of severe acne. Depression, suicidal ideation, and psychosis are among the most well-documented psychiatric side effects. Here, we report a case of isotretinoin-induced psychosis, which was diagnosed as delusiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Katharine V., Abba-Aji, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399729/
https://www.ncbi.nlm.nih.gov/pubmed/32774942
http://dx.doi.org/10.1155/2020/8853167
_version_ 1783566198944825344
author Jensen, Katharine V.
Abba-Aji, Adam
author_facet Jensen, Katharine V.
Abba-Aji, Adam
author_sort Jensen, Katharine V.
collection PubMed
description Isotretinoin, an active form of vitamin A, is the drug of last resort for the treatment of severe acne. Depression, suicidal ideation, and psychosis are among the most well-documented psychiatric side effects. Here, we report a case of isotretinoin-induced psychosis, which was diagnosed as delusional disorder somatic subtype, in a young male in the absence of any prodromal symptoms, previous psychiatric history, or family history of mental illness. The onset of psychosis was in the context of a dosage increase from 40 mg/day to 80 mg/day. Isotretinoin was discontinued, and the patient showed improvement on low-dose quetiapine.
format Online
Article
Text
id pubmed-7399729
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-73997292020-08-07 Isotretinoin-Induced Delusional Disorder, Somatic Subtype Jensen, Katharine V. Abba-Aji, Adam Case Rep Dermatol Med Case Report Isotretinoin, an active form of vitamin A, is the drug of last resort for the treatment of severe acne. Depression, suicidal ideation, and psychosis are among the most well-documented psychiatric side effects. Here, we report a case of isotretinoin-induced psychosis, which was diagnosed as delusional disorder somatic subtype, in a young male in the absence of any prodromal symptoms, previous psychiatric history, or family history of mental illness. The onset of psychosis was in the context of a dosage increase from 40 mg/day to 80 mg/day. Isotretinoin was discontinued, and the patient showed improvement on low-dose quetiapine. Hindawi 2020-07-25 /pmc/articles/PMC7399729/ /pubmed/32774942 http://dx.doi.org/10.1155/2020/8853167 Text en Copyright © 2020 Katharine V. Jensen and Adam Abba-Aji. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Jensen, Katharine V.
Abba-Aji, Adam
Isotretinoin-Induced Delusional Disorder, Somatic Subtype
title Isotretinoin-Induced Delusional Disorder, Somatic Subtype
title_full Isotretinoin-Induced Delusional Disorder, Somatic Subtype
title_fullStr Isotretinoin-Induced Delusional Disorder, Somatic Subtype
title_full_unstemmed Isotretinoin-Induced Delusional Disorder, Somatic Subtype
title_short Isotretinoin-Induced Delusional Disorder, Somatic Subtype
title_sort isotretinoin-induced delusional disorder, somatic subtype
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399729/
https://www.ncbi.nlm.nih.gov/pubmed/32774942
http://dx.doi.org/10.1155/2020/8853167
work_keys_str_mv AT jensenkatharinev isotretinoininduceddelusionaldisordersomaticsubtype
AT abbaajiadam isotretinoininduceddelusionaldisordersomaticsubtype